Atrophin 1 抗体 (C-Term)
Quick Overview for Atrophin 1 抗体 (C-Term) (ABIN1978564)
抗原
See all Atrophin 1 (ATN1) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1150-1190, C-Term
- 
                                            特异性
- Region between residue 1150 and the C-terminus (residue 1190) of human Atrophin 1 using the numbering given in entry NP_001007027.1 (GeneID 1822 ).
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: IP (3 - 5 μg/mg lysate), WB (1:500 - 1:2500)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C
- 
                                            储存方法
- Store at 2-8°C for up to 1 year.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - Atrophin 1 (ATN1)
- 
                                            别名
- DRPLA / Atrophin-1
- 
                                            背景
- 
                        Name/Gene ID: ATN1
 Synonyms: ATN1, B37, Atrophin 1, D12S755E, NOD, HRS, Atrophin-1, DRPLA
- 
                                            基因ID
- 1822
 抗原
- 
                    
 
                                     
                                     
                                    